This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A phase II randomised, double blind, placebo-contr...
Clinical trial

A phase II randomised, double blind, placebo-controlled study to evaluate the efficacy, safety and tolerability of CT327 topical ointment (0.05% and 0.5% w/w) compared to vehicle, in subjects with mild or moderate atopic dermatitis with at least moderate

Read time: 1 mins
Last updated:19th Mar 2013
The main objectives of the study are: To determine whether CT327 is effective in reducing pruritus (itch) in subjects with atopic dermatitis, using a pruritus visual analogue scale (VAS) To assess the efficacy of CT327 on atopic dermatitis using the Investigator Global Assessment (IGA)
Category Value
Study start date 2013-03-19

View full details